sales@theinsightpartners.com
+1-646-491-9876 +44-20-8125-4005

Asia Pacific Liposome Drug Delivery Market Scope And Analysis

  • Report Code : TIPRE00014175
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 147
Buy Now

Asia Pacific Liposome Drug Delivery Market Scope and Key Players Analysis by 2027

Buy Now

Asia Pacific Liposome Drug Delivery Market Report Asia Pacific Liposome Drug Delivery Market Size and Share Asia Pacific Liposome Drug Delivery Market Scope and Analysis

Asia Pacific Liposome Drug Delivery Market Report Scope

Report Attribute Details
Market size in 2019 US$ 759.81 Million
Market Size by 2027 US$ 1,562.92 Million
Global CAGR (2020 - 2027) 9.6%
Historical Data 2017-2018
Forecast period 2020-2027
Segments Covered By Product
  • Liposomal Doxorubicin
  • Liposomal Paclitaxel
  • Liposomal Amphotericin B
By Technology
  • Stealth Liposome Technology
  • Non-PEGylated Liposome Technology
  • DepoFoam Liposome Technology
  • Lysolipid Thermally Sensitive Liposome Technology
By Application
  • Fungal Diseases
  • Cancer Therapy
  • Pain Management
  • Viral Vaccines
  • Photodynamic Therapy
Regions and Countries Covered Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
Market leaders and key company profiles
  • ASTELLAS PHARMA INC
  • JOHNSON AND JOHNSON SERVICES INC
  • LUYE PHARMA GROUP
  • TAKEDA PHARMACEUTICAL COMPANY LIMITED
  • Novartis AG
  • Ipsen Pharma
  • Gilead Sciences Inc
  • Celsion Inc